シンポジウム16‐5 神経疾患とRNA SCA31(脊髄小脳失調症31型)

DOI PubMed 参考文献10件 オープンアクセス
  • 石川 欽也
    東京医科歯科大学大学院脳神経病態学
  • 佐藤 望
    東京医科歯科大学大学院脳神経病態学
  • 新美 祐介
    東京医科歯科大学大学院脳神経病態学
  • 網野 猛志
    東京医科歯科大学大学院脳神経病態学 現 日本赤十字社武蔵野赤十字病院神経内科
  • 水澤 英洋
    東京医科歯科大学大学院脳神経病態学

書誌事項

タイトル別名
  • Spinocerebellar ataxia type 31

説明

Spinocerebellar ataxia type 31 (SCA31) is a relatively common degenerative ataxia in Japan. We recently discovered SCA31 mutation as a complex pentanucleotide repeat containing (TAAAA)n, (TAGAA)n, and (TGGAA)n. The size of this repeat ranged from 2.8 to 3.5 kilo-base pairs (kb). Among these repeats, (TGGAA)n repeat appears crucial for SCA31 pathogenesis. The length of this complex repeat inversely correlated with ages of onset in patients. The mutation lies in an intron shared by two different genes, BEAN (brain expressed, associated with NEDD4) and TK2 (thymidine kinase 2), which are transcribed in opposite directions. Thus, the complex pentanucleotide sequence is predicted to be transcribed in both directions, but not necessarily translated into proteins. In situ hybridization analysis in patients' Purkinje cells demonstrated that pentanucleotide repeats transcribed in BEAN direction form RNA aggregates ("RNA foci"). We further found that splicing factors, SFRS1 and SFRS9, binds to (UGGAA)n, the transcript of (TGGAA)n in vitro. These findings may imply that SCA31 conforms to pathogenic mechanisms underlying non-coding repeat disorders, such as myotonic dystrophies (DM1 & DM2), and that SFRS1 and SFRS9 are involved in SCA31 pathogenesis.<br>

収録刊行物

  • 臨床神経学

    臨床神経学 50 (11), 985-987, 2010

    日本神経学会

参考文献 (10)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1390282680013899136
  • NII論文ID
    130004504728
  • DOI
    10.5692/clinicalneurol.50.985
  • ISSN
    18820654
    0009918X
  • PubMed
    21921537
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • Crossref
    • CiNii Articles
    • OpenAIRE
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ